Answer
No, Abecma (idecabtagene vicleucel) is solely for autologous use and must never be administered to another patient or when its labels and release for infusion certificate do not match the patient's identity.
Sources for this answer
- Abecma 260 - 500 x 10^6 cells dispersion for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked